Ayala Pharmaceuticals Announces Continuation of RINGSIDE Phase 2/3 Study in Desmoid Tumors Following Recommendation of Independent Data Monitoring Committee
March 03, 2023 08:00 ET
|
Ayala Pharmaceuticals
Registration-enabling Phase 3 segment of RINGSIDE is enrolling patients globally Updated data on AL102 Phase 2 segment of RINGSIDE are planned for presentation at a medical meeting in 2023 ...
Ayala Pharmaceuticals Reports Financial Results For the Fiscal Year Ended October 31, 2022
February 10, 2023 07:00 ET
|
Ayala Pharmaceuticals
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (f/k/a Advaxis Inc.) (the “Company,” “New Ayala,” “we,” “us” or “our”) (OTCQX: ADXS), a...
Access Recognized in Two Categories by Inc.’s Prestigious Inaugural Power Partner Awards
January 24, 2023 11:30 ET
|
Access Information Management Shared Services, LLC
WOBURN, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Access, the world’s largest privately-held integrated information management services provider, today announced that it has been recognized by Inc....
Advaxis and Ayala Pharmaceuticals Complete Merger
January 19, 2023 09:37 ET
|
Advaxis, Inc.
REHOVOT, Israel and WILMINGTON, Del. and MONMOUTH JUNCTION, N.J., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Advaxis, Inc. (OTCQX: ADXS), a biotechnology company devoted to the discovery, development and...
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer
January 12, 2023 08:04 ET
|
Advaxis, Inc.
Dose escalation has been completed and enrollment at second dose level will be expanded at Columbia University ADXS-504 has been well tolerated with no serious adverse events reportedFour out of six...
HPV Associated Disorders Global Market Report 2022: Ukraine-Russia War Impact
December 20, 2022 06:12 ET
|
ReportLinker
New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "HPV Associated Disorders Global Market Report 2022: Ukraine-Russia War Impact" -...
MamaMancini’s Appoints Meghan Henson to Board of Directors
December 19, 2022 08:31 ET
|
MamaMancini's Holdings, Inc.
Seasoned Human Resources Executive Brings 20+ Years of Experience to the Board of Directors EAST RUTHERFORD, NJ, Dec. 19, 2022 (GLOBE NEWSWIRE) -- MamaMancini's Holdings, Inc. (NASDAQ: MMMB), a...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AYLA, MYOV, USER, AGFS
November 20, 2022 10:45 ET
|
Halper Sadeh LLC
NEW YORK, Nov. 20, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
Crawford Thomas Recruiting Named to Inc.’s Power Partner Awards
November 16, 2022 11:28 ET
|
Crawford Thomas Recruiting
ORLANDO, Fla., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Crawford Thomas Recruiting, the leading nationwide recruiting and staffing firm, announced it has been honored in Inc. Business Media’s inaugural...
Ayala Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 04, 2022 08:00 ET
|
Ayala Pharmaceuticals
Entered into a definitive merger agreement with Advaxis Inc. – transaction expected to close by end of Q1 2023, subject to approval by Ayala’s shareholders and the satisfaction of customary closing...